Bafna Pharmaceuticals Ltd.
BSE: 532989 |
Sector: Health care |
NSE: BAFNAPHARM |
ISIN Code: INE878I01014 |
BSE
00:00 | 20 Apr
|
29.00
|
0.25 (0.87%)
|
OPEN
28.00
|
HIGH
29.00
|
LOW
28.00
|
NSE
00:00 | 20 Apr
|
28.95
|
-0.40 (-1.36%)
|
OPEN
29.50
|
HIGH
29.50
|
LOW
28.90
|
OPEN |
28.00 |
PREVIOUS CLOSE |
28.75 |
VOLUME |
1188 |
52-Week high |
32.40 |
52-Week low |
20.00 |
P/E |
5.79 |
Mkt Cap.(Rs cr) |
54 |
Buy Price |
0.00 |
Buy Qty |
0.00 |
Sell Price |
0.00 |
Sell Qty |
0.00 |
OPEN |
29.50 |
PREVIOUS CLOSE |
29.35 |
VOLUME |
7190 |
52-Week high |
32.50 |
52-Week low |
22.00 |
P/E |
5.79 |
Mkt Cap.(Rs cr) |
54 |
Buy Price |
0.00 |
Buy Qty |
0.00 |
Sell Price |
0.00 |
Sell Qty |
0.00 |
OPEN |
28.00 |
CLOSE |
28.75 |
VOLUME |
1188 |
52-Week high |
32.40 |
52-Week low |
20.00 |
P/E |
5.79 |
Mkt Cap.(Rs cr) |
54 |
Buy Price |
0.00 |
Buy Qty |
0.00 |
Sell Price |
0.00 |
Sell Qty |
0.00 |
OPEN |
29.50 |
PREVIOUS CLOSE |
29.35 |
VOLUME |
7190 |
52-Week high |
32.50 |
52-Week low |
22.00 |
P/E |
5.79 |
Mkt Cap.(Rs cr) |
54.11 |
Buy Price |
0.00 |
Buy Qty |
0.00 |
Sell Price |
0.00 |
Sell Qty |
0.00 |
Filter:
Bafna Pharmaceuticals Ltd. (BAFNAPHARM) - Nine Monthly Result
Particulars ( cr) |
Dec '17 |
Dec '16 |
Dec '15 |
Dec '14 |
Dec '13 |
Net Sales/Income From Operations |
30.65 |
53.52 |
59.04 |
123.80 |
138.25 |
Other Income |
30.33 |
1.15 |
1.22 |
0.73 |
1.03 |
Total Income |
60.98 |
54.67 |
60.26 |
124.53 |
139.28 |
Total Expenditure |
32.89 |
52.69 |
53.73 |
77.68 |
121.07 |
Operating Profit |
28.09 |
1.98 |
6.52 |
46.85 |
18.21 |
Interest |
5.78 |
9.19 |
9.04 |
9.79 |
8.66 |
Gross Profit |
22.30 |
-7.21 |
-2.52 |
37.06 |
9.55 |
Depreciation |
2.88 |
3.05 |
2.35 |
4.88 |
4.50 |
PBT |
17.72 |
-10.10 |
-4.87 |
32.18 |
5.05 |
Tax |
0.00 |
0.00 |
0.47 |
3.30 |
1.71 |
Net Profit/(Loss) |
17.72 |
-10.10 |
-5.34 |
28.88 |
3.34 |
Minority Interest After NP |
- |
- |
- |
- |
- |
Net Profit after Minority Interest |
- |
- |
- |
- |
- |
Exceptional Items |
0.00 |
0.00 |
0.00 |
-2.41 |
0.00 |
Profit After Exceptional Items |
17.72 |
-10.10 |
-5.34 |
31.29 |
3.34 |
Equity Share Capital |
18.66 |
18.66 |
18.66 |
18.66 |
18.66 |
Reserves Excluding Revaluation Reserves |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
EPS |
Basic EPS |
9.50 |
-5.41 |
-2.86 |
15.48 |
1.79 |
Public Share Holding |
No Of Shares (Crores) |
0 |
0 |
0 |
0.12 |
1.18 |
Share Holding (%) |
0.00 |
0.00 |
0.00 |
63.05 |
63.50 |
Promoters and Promoter Group Shareholding |
a) Pledged/Encumbered |
- Number of Shares (Crores) |
0 |
0 |
0 |
0.15 |
0.15 |
- Per. of Shares (as a % of the total sh. of prom. and promoter group) |
0.00 |
0.00 |
0.00 |
22.19 |
22.47 |
- Per. of Shares (as a % of the total Share Cap. of the company) |
0.00 |
0.00 |
0.00 |
8.20 |
8.20 |
b) Non-encumbered |
- Number of Shares (Crores) |
0 |
0 |
0 |
0.54 |
0.53 |
- Per. of shares (as a % of the total sh. of prom. and promoter group) |
0.00 |
0.00 |
0.00 |
77.81 |
77.53 |
- Per. of shares (as a % of the total Share Cap. of the company) |
0.00 |
0.00 |
0.00 |
28.75 |
28.30 |
Note :
|
PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. |
Quick Links for Bafna Pharmaceuticals: